Top 10 astellasgenetherapies.com Competitors

nurixtx.com

Browse current openings at Nurix across research, clinical, and business roles. Find your next opportunity. We'd love to hear from you.

corvuspharma.com

corvus pharmaceuticals is a clinical science-driven biopharmaceutical company focused on the development of cleverly-designed medicines with precise mechanisms of action to improve the lives of patients with the most difficult-to-treat cancers.

mazetx.com

Last Revised: December 19, 2018 Welcome to Maze! Please read the following terms and conditions of use (the “Terms of Use”) carefully before using this website at www.mazetx.com or its subdomains (this “Website”).  Your use of this Website is subject to,...

assemblybio.com

Passionate about making a profound impact on peoples’ lives Assembly Bio is an ambitious biopharmaceutical company with cutting-edge therapeutic candidates capable of improving the lives of millions living with devastating viral and liver diseases. We have multiple ongoing clinical programs focused on the development of novel treatments for herpesviruses, hepatitis delta virus (HDV), cholestatic liver […]

aligos.com

With experience in developing therapeutics for chronic liver diseases and viral infections, we are building best-in-class drug candidates.

allogene.com

CAREERS At Allogene, you’ll find an experienced, high-performing team of employees whose sole focus is to transform the treatment of cancer and autoimmune disease. Our deep pipeline of innovative AlloCAR T products is based on an allogeneic platform enabled by validated gene editing and advanced proprietary cell-manufacturing technologies. We are on our way to building […]

vial.com

Stay in the know about everything Vial with our latest press releases. Keep up-to-date on our innovations, milestones, and industry impact.

mbcbiolabs.com

Enjoy our August newsletter!

nektar.com

Explore biotechnology careers at Nektar Therapeutics. Join our innovative team developing life-changing therapies.

eurekatherapeutics.com

The first patient with GPC3-positive advanced hepatocellular carcinoma (HCC), the predominant type of liver cancer, was treated with ECT204 T cell therapy.